SCHEDULE: BlackRock Discloses 4.3% Stake in AVITA Medical

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 4.3% beneficial ownership stake in AVITA Medical, Inc. as of September 30, 2025.

Summary

• BlackRock, Inc. reported beneficial ownership of 1,138,436 shares of AVITA Medical, Inc. common stock.
• This represents 4.3% of the class of securities.
• The filing is an Amendment No. 1 to a Schedule 13G, indicating an update to a previous filing.
• BlackRock holds sole voting power over 1,119,786 shares and sole dispositive power over 1,138,436 shares.
• The shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of AVITA Medical, Inc.
• The filing was made under Rule 13d-1(b), typically used by institutional investors with passive investment intent.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. The filing is a routine ownership disclosure by a major institutional investor, indicating a stable, passive stake. No negative information is presented, and the presence of a large institutional holder can be seen as a positive signal.

Positives

• A major institutional investor, BlackRock, holds a significant stake, which can be interpreted as a vote of confidence in AVITA Medical.
• The passive nature of the investment (filed under Rule 13d-1(b)) suggests BlackRock is not seeking to influence management or control, which can be seen as a stable investment.

Future Outlook

This filing does not contain any forward-looking statements or guidance from AVITA Medical or BlackRock regarding AVITA Medical's future performance. It is solely a disclosure of ownership.

Management Comments

• The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities.

Industry Context

This filing primarily reflects an institutional investment position rather than specific industry trends. AVITA Medical operates in the medical device sector, and BlackRock's investment signifies its presence in this market segment.

Corporate Governance

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional holder's stake, potentially influencing investor sentiment.
• Management: Confirms a passive investment by a major institutional investor, reducing immediate pressure for strategic changes from this shareholder.

Next Steps

• No specific future actions or milestones for AVITA Medical are mentioned in this ownership disclosure. BlackRock will continue to monitor its investment and file updates as required by SEC regulations.

Key Dates

Recommendation

This Schedule 13G filing is a routine disclosure of a passive investment by BlackRock, Inc. in AVITA Medical, Inc. It indicates a stable, non-controlling stake below the 5% threshold. The filing does not contain any financial performance data, strategic updates, or other information that would warrant a change in investment thesis. Therefore, for existing investors, a 'hold' recommendation is appropriate as there's no new fundamental information to alter their position. For new investors, the filing itself does not provide sufficient data for a 'buy' or 'sell' decision, as it lacks operational and financial details.

Keywords

BlackRock, AVITA Medical, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, Healthcare, Medical Devices